United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News FDA approves Ambio’s generic version of Forteo developed in collaboration with Apotex Ambio, Inc., a leader in biotech innovation specializing in peptide drugs and complex generics, has announced that its… byPallavi MadhirajuDecember 3, 2023